Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease
| Image |  |
|---|---|
| Description | scientific article published on 09 September 2019 |
| Author/s |
author: Satoshi Ebata |
| Publication date | September 9, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |